Restless legs syndrome (RLS) is a chronic, usually idiopathic disorder characterized by uncontrollable urges to move the legs or arms at night along with unpleasant sensations in the affected limbs.
Nat Clin Pract Endocrinol Metab. 2006;2(6):298-299. Clearly, dopamine agonists should not be withdrawn too early, and certainly not before completion of 12 months' treatment. Until more is known about ...
– ALTO-207 (fka CTC-501) is a fixed-dose combination of pramipexole and ondansetron designed to induce rapid antidepressant effects while mitigating dose-limiting adverse events of pramipexole – – ...
INDIANAPOLIS — The guidelines for restless legs syndrome treatment no longer indicate dopamine agonists as a first-line choice, John Winkelman, MD, PhD, says in this Healio video from SLEEP 2023.
People who suffer from agonising restless leg syndrome may be at greater risk of developing Parkinson's disease, concerning research has suggested. The condition, which affects up to 10 per cent of ...
A new study on laboratory rats has found that the brain’s ability to learn from rewards is enhanced by the hormone estrogen.
Meanwhile, beta blocker medications tend to reduce REM sleep, which is when most dreaming occurs, but research has found that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback